BAYLEE WILDMAN: Open Payments
NPI 1891450151 · MARION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,610 in 83 payments from 9 companies in 2025. Trend: 2023 $1,164 · 2024 $1,516 · 2025 $1,610
Food & beverage: $1,610
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $417 |
| UCB, Inc. | 13 | $289 |
| ABBVIE INC. | 26 | $257 |
| Galderma Laboratories, L.P. | 11 | $230 |
| Kerecis Limited | 3 | $154 |
| GENZYME CORPORATION | 5 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| LEO Pharma Inc. | 1 | $21 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, SKYRIZI, Kerecis SurgiClose, DUPIXENT, RINVOQ, Sotyktu.
Industry payments across IN — which companies pay providers there.
